KIYATEC To Present Immuno-Oncology Response Characterization at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting posted on November 5, 2019Emerging evidence of in vitro T-cell mediated tumor cytotoxicity holds promise for I/O drug developers GREENVILLE, S.C. – November 5, 2019 KIYATEC, Inc. today announced that it will present …Continue Reading about KIYATEC To Present Immuno-Oncology Response Characterization at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting →